Literature DB >> 22076328

Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.

Verena D Schwab1, Mathias Sulk, Stephan Seeliger, Pawel Nowak, Jerome Aubert, Christian Mess, Michel Rivier, Isabelle Carlavan, Patricia Rossio, Dieter Metze, Jörg Buddenkotte, Ferda Cevikbas, Johannes J Voegel, Martin Steinhoff.   

Abstract

Rosacea is a common skin disease with a high impact on quality of life. Characterized by erythema, edema, burning pain, immune infiltration, and facial skin fibrosis, rosacea has all the characteristics of neurogenic inflammation, a condition induced by sensory nerves via antidromically released neuromediators. To investigate the hypothesis of a central role of neural interactions in the pathophysiology, we analyzed molecular and morphological characteristics in the different subtypes of rosacea by immunohistochemistry, double immunofluorescence, morphometry, real-time PCR, and gene array analysis, and compared the findings with those for lupus erythematosus or healthy skin. Our results showed significantly dilated blood and lymphatic vessels. Signs of angiogenesis were only evident in phymatous rosacea. The number of mast cells and fibroblasts was increased in rosacea, already in subtypes in which fibrosis is not clinically apparent, indicating early activation. Sensory nerves were closely associated with blood vessels and mast cells, and were increased in erythematous rosacea. Gene array studies and qRT-PCR confirmed upregulation of genes involved in vasoregulation and neurogenic inflammation. Thus, dysregulation of mediators and receptors implicated in neurovascular and neuroimmune communication may be crucial at early stages of rosacea. Drugs that function on neurovascular and/or neuroimmune communication may be beneficial for the treatment of rosacea.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076328      PMCID: PMC3704331          DOI: 10.1038/jidsymp.2011.6

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  46 in total

1.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.

Authors:  M Steinhoff; N Vergnolle; S H Young; M Tognetto; S Amadesi; H S Ennes; M Trevisani; M D Hollenberg; J L Wallace; G H Caughey; S E Mitchell; L M Williams; P Geppetti; E A Mayer; N W Bunnett
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

Review 2.  Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

Authors:  Martin Steinhoff; Jörg Buddenkotte; Jerome Aubert; Mathias Sulk; Pawel Novak; Verena D Schwab; Christian Mess; Ferda Cevikbas; Michel Rivier; Isabelle Carlavan; Sophie Déret; Carine Rosignoli; Dieter Metze; Thomas A Luger; Johannes J Voegel
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

Review 3.  Modern aspects of cutaneous neurogenic inflammation.

Authors:  Martin Steinhoff; Sonja Ständer; Stephan Seeliger; John C Ansel; Martin Schmelz; Thomas Luger
Journal:  Arch Dermatol       Date:  2003-11

4.  Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.

Authors:  Stephan Seeliger; Jörg Buddenkotte; Anjona Schmidt-Choudhury; Carine Rosignoli; Victoria Shpacovitch; Ulrike von Arnim; Dieter Metze; Roman Rukwied; Martin Schmelz; Ralf Paus; Johannes J Voegel; Wolfgang E Schmidt; Martin Steinhoff
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

5.  Relative roles of doxycycline and cation chelation in endothelial glycan shedding and adhesion of leukocytes.

Authors:  Herbert H Lipowsky; Rachna Sah; Anne Lescanic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

6.  TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes.

Authors:  Kenshi Yamasaki; Kimberly Kanada; Daniel T Macleod; Andrew W Borkowski; Shin Morizane; Teruaki Nakatsuji; Anna L Cogen; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2010-11-25       Impact factor: 8.551

7.  The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures.

Authors:  Michael J Monument; David A Hart; A Dean Befus; Paul T Salo; Mei Zhang; Kevin A Hildebrand
Journal:  J Bone Joint Surg Am       Date:  2010-06       Impact factor: 5.284

8.  Staphylococcus epidermidis: a possible role in the pustules of rosacea.

Authors:  Margot Whitfeld; Nishmi Gunasingam; Liang Joo Leow; Kyoko Shirato; Veronica Preda
Journal:  J Am Acad Dermatol       Date:  2010-10-12       Impact factor: 11.527

Review 9.  Mast cells in the pathogenesis of fibrosis.

Authors:  Barry L Gruber
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

10.  Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.

Authors:  Reto Huggenberger; Stefan Ullmann; Steven T Proulx; Bronislaw Pytowski; Kari Alitalo; Michael Detmar
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

View more
  54 in total

Review 1.  Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

Authors:  Martin Steinhoff; Jörg Buddenkotte; Jerome Aubert; Mathias Sulk; Pawel Novak; Verena D Schwab; Christian Mess; Ferda Cevikbas; Michel Rivier; Isabelle Carlavan; Sophie Déret; Carine Rosignoli; Dieter Metze; Thomas A Luger; Johannes J Voegel
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

Review 2.  Rosacea: new and emerging treatments.

Authors:  Farah A Moustafa; Laura F Sandoval; Steven R Feldman
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

3.  Pituitary Adenylate Cyclase-Activating Polypeptide Is Upregulated in Murine Skin Inflammation and Mediates Transient Receptor Potential Vanilloid-1-Induced Neurogenic Edema.

Authors:  Zsuzsanna Helyes; Jozsef Kun; Nora Dobrosi; Katalin Sándor; Jozsef Németh; Aniko Perkecz; Erika Pintér; Krisztina Szabadfi; Balazs Gaszner; Valeria Tékus; Janos Szolcsányi; Martin Steinhoff; Hitoshi Hashimoto; Dora Reglődi; Tamas Bíró
Journal:  J Invest Dermatol       Date:  2015-04-23       Impact factor: 8.551

Review 4.  Flushing Disorders Associated with Gastrointestinal Symptoms: Part 2, Systemic Miscellaneous Conditions.

Authors:  Vaibhav Rastogi; Devina Singh; Joseph J Mazza; Dipendra Parajuli; Steven H Yale
Journal:  Clin Med Res       Date:  2018-04-12

5.  Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways.

Authors:  Timo Buhl; Mathias Sulk; Pawel Nowak; Jörg Buddenkotte; Ian McDonald; Jérôme Aubert; Isabelle Carlavan; Sophie Déret; Pascale Reiniche; Michel Rivier; Johannes J Voegel; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2015-04-07       Impact factor: 8.551

Review 6.  Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit.

Authors:  Aimee M Two; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2014-01

7.  Compliance and Subjective Patient Responses to Eyelid Hygiene.

Authors:  Yousef A Alghamdi; Andrew Camp; William Feuer; Carol L Karp; Sarah Wellik; Anat Galor
Journal:  Eye Contact Lens       Date:  2017-07       Impact factor: 2.018

8.  Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

Authors:  J Fowler; M Jarratt; A Moore; K Meadows; A Pollack; M Steinhoff; Y Liu; M Leoni
Journal:  Br J Dermatol       Date:  2012-03       Impact factor: 9.302

Review 9.  Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

Review 10.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.